BrightSpring Health Services, Inc. (BTSG) Stock Forecast
BTSG analyst forecast
as of October 17, 2026- Analyst consensus
- Strong buy 4.83 / 5 from 18 analysts
- Price target
- $78.94 average of analyst targets
- Upside to target
- +29.7% from the latest close
- Next earnings
- October 30, 2026 EPS estimate $0.45
- 52-week range
- $30.47 – $72.91
BTSG analyst ratings
18 analystsNumber of analysts at each rating.
BTSG price target
The average of analyst 12-month price targets compared with the latest close and the 52-week range.
BTSG earnings per share estimates
| Period | Average | Low | High | Year ago | Growth | Analysts |
|---|---|---|---|---|---|---|
| Current quarter (Sep '26) | $0.47 | $0.36 | $0.58 | $0.30 | +57.0% | 16 |
| Current fiscal year (2026) | $1.82 | $1.61 | $2.08 | $1.00 | +82.0% | 17 |
| Next fiscal year (2027) | $2.28 | $1.68 | $2.65 | $1.82 | +25.2% | 17 |
Consensus EPS estimates; growth compares the average estimate with the year-ago EPS.
BTSG revenue estimates
| Period | Average | Low | High | Growth | Analysts |
|---|---|---|---|---|---|
| Current quarter (Sep '26) | $3.87B | $3.76B | $3.93B | +16.2% | 15 |
| Current fiscal year (2026) | $15.37B | $15.26B | $15.52B | +19.0% | 17 |
| Next fiscal year (2027) | $17.43B | $16.98B | $18.54B | +13.4% | 18 |
BTSG EPS: reported and forecast
Fiscal years; "E" marks estimates, the line shows the range from the lowest to the highest estimate.
BTSG revenue: reported and forecast
BTSG EPS estimate revisions
| Period | 90 days ago | 60 days ago | 30 days ago | 7 days ago | Now | Change (90 d) | Revisions (30 d) |
|---|---|---|---|---|---|---|---|
| Current quarter (Sep '26) | $0.44 | $0.47 | $0.47 | $0.47 | $0.47 | +7.9% | 12 up · 0 down |
| Current fiscal year (2026) | $1.69 | $1.82 | $1.82 | $1.82 | $1.82 | +7.7% | 1 up · 0 down |
| Next fiscal year (2027) | $2.12 | $2.28 | $2.28 | $2.28 | $2.28 | +7.2% | 14 up · 0 down |
How the consensus EPS estimate changed over the last 90 days, and how many analysts raised or lowered it in the last 30 days.
BTSG earnings surprises
Reported EPS vs the consensus estimate for the last 11 quarters; BTSG beat in 9 of 11.
What analysts expect from BTSG
18 analysts cover BrightSpring Health Services; their consensus rating is strong buy (4.83 on a 1–5 scale, where 5 is a strong buy). The average price target is $78.94, 29.7% above the latest close of $60.87. Analysts expect earnings of $1.82 per share for 2026, +82.0% from a year earlier. For 2027 the average estimate is $2.28 per share on revenue of $17.4 billion. BrightSpring Health Services beat the EPS estimate in 9 of the last 11 quarters.
Related: BTSG income statement, BTSG key metrics, BTSG chart. See the BTSG stock overview for the latest quote and news.
BTSG forecast FAQ
What is BrightSpring Health Services's price target?
The average analyst price target for BrightSpring Health Services is $78.94, 29.7% above the latest close of $60.87.
Is BrightSpring Health Services a buy, hold or sell?
Of 18 analysts covering BrightSpring Health Services, 15 rate it a strong buy, 3 a buy, 0 a hold, 0 a sell and 0 a strong sell, a consensus of strong buy. Ratings are opinions, not a recommendation from Quotelinks.
What is BrightSpring Health Services's EPS forecast?
Analysts forecast $1.82 per share for 2026 (range $1.61 to $2.08); for 2027 the estimate is $2.28.
What is BrightSpring Health Services's revenue forecast?
The average revenue estimate for 2026 is $15.4 billion, growth of 19.0%; for 2027 it is $17.4 billion.
When does BrightSpring Health Services report earnings?
BrightSpring Health Services is expected to report results for the quarter ending September 30, 2026 on October 30, 2026 before the market opens; the EPS estimate is $0.45.
Does BrightSpring Health Services usually beat earnings estimates?
BrightSpring Health Services reported EPS at or above the analyst estimate in 9 of the last 11 quarters.